Traumatic brain injury and β-blockers: Not all drugs are created equal

Journal of Trauma and Acute Care Surgery

Volumn 76, Issue 2, 2014, Pages 504-509

  Schroeppel, Thomas J ^a   Sharpe, John P ^a   Magnotti, Louis J ^a   Weinberg, Jordan A ^a   Clement, L Paige ^a   Croce, Martin A ^a   Fabian, Timothy C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

dysautonomia; propranolol; Trauma

Indexed keywords

ADRENERGIC BETA-ANTAGONISTS; ADULT; BRAIN INJURIES; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLASGOW COMA SCALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PRIMARY DYSAUTONOMIAS; PROPRANOLOL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TRAUMA CENTERS;

EID: 84894151896     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000104     Document Type: Article

References (39)

1. Brain Trauma Foundation. TBI Statistics. Available at: https://www. braintrauma.org/tbi-faqs/tbi-statistics. Accessed August 29, 2013.
2. Langlois J, Rutland-Brown W, Wald M. The Epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehab. 2006;21: 375-378.
3. Shackford SR, Mackersie RC, HolBrook TL, Davis JW, Hollingsworth-Fridlund P, Hoyt DB, Wolf PL. The epidemiology of traumatic death: a population-based analysis. Arch Surg. 1993;128:571-575.
4. Thurman D, Guerro J. Trends in hospitalization associated with traumatic brain injury. JAMA. 1999;282:954-957.
5. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, Hoyt DB. Lethal injuries and time to death in a Level I trauma center. J Am Coll Surg. 1998;186:528-533.
6. Rossitch E Jr, Bullard DE. The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg. 1988;2;471-478.
7. Hamill RW, Woolf PD, McDonald JV, Lee LA, Kelly M. Catecholamines predict outcome in traumatic brain injury. Ann Neurol. 1987;21:438-443.
8. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, Glockner F, Lanksch WR, Volk HD, DockeWD. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808-813.
9. Clifton GL, Ziegler MG, Grossman RG. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery. 1981;8:10-14.
10. Freibel JH, Baldwin CA, Joynt RJ. Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol. Ann Neurol. 1981;9:340-343.
11. Naredi S, Lambert G, Eden E, Zall S, Runnerstam M, Rydenhag B, Friberg P. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke. 2000;31:901-906.
12. Inaba K, Teizeira P, David J, Chan LS, Salim A, Brown C, Browder T, Beale E, Rhee P, Demtriades D. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206:432-438.
13. Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, Morris JA Jr. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26-35.
14. Riordan Jr WP, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA Jr. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007;63:503-511.
15. Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, Niederbichler AD, Ipaktchi K, Wahl WL. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62: 56-62.
16. Woolf PD, Hamill RW, Lee LA, Cox C, McDonald JV. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg. 1987;66:875-882.
17. Schroeppel TJ, Fischer PE, Zarzaur BL, Magnotti LJ, Clement LP, Fabian TC, Croce MA. Beta-adrenergic blockade and traumatic brain injury: protective? J Trauma. 2010;69:776-782.
18. Heffernan DS, Inaba K, Arbabi S, Cotton BA. Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy. J Trauma. 2010;69:1602-1609.
19. Hortnagl H, Hammerle AF, Hackl JM, Brucke T, Rumpl E, Hortnagl H. The activity of sympathetic nervous system following severe head injury. Intensive Care Med. 1980;6:169-177.
20. Grunsfeld A, Fletcher JJ, Nathan BR. Cardiopulmonary complications of brain injury. Curr Neurol Neurosci Rep. 2005;5:488-493.
21. Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol. 1988;12:600-605.
22. McLeod AA, Neil-Dwyer G, Meyer CH, Richardson PL, Cruickshank J, Bartlett J. Cardiac sequelae of acute head injury. Br Heart J. 1982;47: 221-226.
23. Neil-Dwyer G,Walter P, Cruickshank JM, Doshi B, O'Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 1978;2:990-992.
24. Elenkov IJ, Hasko G, Kovacs KJ, Vivi ES. Modulation of liposaccharideinduced tumor necrosis factor-alpha production by selective alpha and beta-adrenergic drugs in mice. J Neuroimmunol. 1995;61:123-131.
25. Randell T, Tanskanen P, Scheinin M, Kytta J, Ohman J, Lindgren L. QT dispersion after subarachnoid hemorrhage. J Neurosurg Anesthiol. 1999;11: 163-166.
26. Weir BK. Pulmonary edema following fatal aneursym rupture. J Neurosurg. 1978;48:502-507.
27. Neil-Dwyer G, Bartlett J, McAinsh J, Cruickshank JM. Beta-adrenoceptor blockers and the blood-brain barrier. Br J Clin Pharmac. 1981;11: 549-553.
28. Ley EJ, Schenet J, Park R, Schroff S, Dagliyan G, Conti PS, Margulies DR, Salim Ali. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009;66:154-161.
29. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345:1223-1229.
30. Woolf PD, McDonald JV, Feliciano D, Kelly MM, Nichols D, Cox C. The catecholamine response to multisystem trauma. Arch Surg. 1992;127: 899-903.
31. Jaatela A, Alho A, Avikainen V, Karaharju E, Kataja J, Lahdensuu M, Lepisto P, Rokkanen P, Tervo T. Plasma catecholamines in severely injured patients: a prospective study on 45 patients with multiple injuries. Br J Surg. 1975;62:177-181.
32. Deng J, Muthu K, Gamelli R, Shankar R, Jones SB. Adrenergic modulation of splenic macrophage cytokine release in polymicobial sepsis. Am J Physiol Cell Physiol. 2004;287:C730-C736.
33. Kalinchenko VV, Mokyr MB, Graf LH Jr, Cohen RL, Chambers DA. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J Immunol. 1999;163:2492-2499.
34. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post stroke T helper cell type 1-like immunostimulation. J ExpMed. 2003;298:725-736.
35. Neil-Dwyer G,Walter P, Cruickshank JM. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol. 1985;28(Suppl): 25-29.
36. Hawkings WE, Clower WH. Myocardial damage after head trauma and simulated intracranial haemorrhage in mice: the role of the autonomic nervous system. Cardiovasc Res. 1971;5:524-529.
37. BukurM,Mosheni S, Ley E, Salim A,Margulies D, Talving P, Demetriades D, Inaba K. Efficacy of beta-blockade after isolated blunt head injury: does race matter? J Trauma Acute Care Surg. 2012;72:1013-1018.
38. Arbabi S, Ahrns KS, Wahl WL, Hemmila MR, Wang SC, Brandt MM, Taheri PA. Beta-blocker use is associated with improved outcomes in adult burn patients. J Trauma. 2004;56:265-271.
39. Liu MY. Protective effective of propranolol on experimentally headinjured mouse brains. J Formos Med Assoc. 1995;94:386-390.